We’ve liked CTD ever since it got on the front foot through the original outbreak of the coronavirus back in 2020 via the acquisition of US business Travel & Transport for just over $US200m, refreshing to see an Aussie company buying as opposed to being bought. So far CTD has corrected over 20% on the news of the concerning fresh strain with the obvious question being is it time to pounce, investors are considering 2 simple factors with regard to highly transmissible Omicron:
- Is the new strain more dangerous and how effective will the current vaccines prove to be.
If we see positive conclusions towards these questions CTD is likely to significantly outperform any bounce in equities and of course vice versa.
MM currently likes CTD under $20
Add To Hit List
